Please login to the form below

Not currently logged in
Email:
Password:

Excellence in Healthcare Collaboration and Partnerships


Excellence in Healthcare Collaboration and Partnerships

Health providers such as the NHS and the pharmaceutical industry share a common agenda to improve patient care outcomes through high quality, cost effective treatment and management. 


The common agenda is to improve patient outcomes through joint working to ensure that patients get optimal care, with support to help them maximise the benefits of treatment. 


Eligible work will demonstrate joint development and implementation of patient-centred projects together with shared commitment to successful delivery. These may have operated at a local or national level.


This category relates to work carried out between July 2011 and December 2012.


Potential entrants might include:


  • Pharmaceutical company brand teams
  • Pharmaceutical company communications teams
  • Healthcare agencies and consultancies. 


Judging criteria:


  • Clear understanding of customer needs and objectives
  • Demonstration of partnership between (two or more) players:
  • shared objectives
  • pooled skills, experience and/or resources 
  • Evidence of sustained relationships and mutual benefit
  • Evidence of changed behaviours and enhanced health outcomes 
  • Customer feedback

Sponsors

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
SEVEN STONES

Seven Stones is a creative, independent healthcare communications agency of movers and thinkers. We've been doing health differently since 1991....

Latest intelligence

“Fake News” and Credibility in Medical Publishing
Natalie Yeadon from Impetus Digital shares her thoughts on fighting fake news in Pharma and healthcare....
Delivering true value: what does it mean for KAM in cancer care?
Lisa Alderson, Business Development Director at Wilmington Healthcare, explores the challenges that pharma’s KAM teams face in engaging with the NHS and how they must evolve...
Pharma M&A
Pharma funding and M&A in 2020
Why pharma M&A has continually bucked the trend...

Infographics